Chen Zhaoming, Yang Yuexia, Qiu Xinyu, Zhou Hao, Wang Rui, Xiong Hu
Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China.
State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Science, College of Life Sciences, Nankai University, Tianjin 300071, China.
J Am Chem Soc. 2024 Dec 11;146(49):34209-34220. doi: 10.1021/jacs.4c14500. Epub 2024 Nov 25.
Systemic mRNA delivery to specific cell types remains a great challenge. We herein report a new class of crown-like biodegradable ionizable lipids (CBILs) for predictable lung-selective mRNA delivery by leveraging the metal coordination chemistry. Each CBIL contains an impressive crown-like amino core that coordinates with various metal ions such as Zn and further regulates the in vivo organ-targeting behavior of lipid nanoparticles (LNPs). The representative CBIL (Zn-9C-SCC-10)-formulated LNPs could exclusively deliver mRNA to the lung after systemic administration. Notably, following intravenous administration of 0.2 mg kg Cre mRNA, Zn-9C-SCC-10 LNPs enabled the highly efficient gene editing of all lung epithelial and endothelial cells up to 43 and 61%, respectively, outperforming the current state-of-the-art LNPs in lung epithelial cell delivery. Moreover, compared to DLin-MC3-DMA LNPs with the addition of cationic lipid (DOTAP), our approach yielded a 44.6-fold enhancement in pulmonary mRNA expression and significantly improved biosafety in vivo. Taking advantage of paramagnetic gadolinium ion, Gd-12C-SCC-10 LNPs allowed the potent mRNA delivery to cancer cells and successfully illuminated lung tumors by magnetic and bioluminescent dual-mode imaging, facilitating the early discovery and diagnosis of lung cancer. This work will open a new avenue to rationally design predictable LNPs, as well as address the major challenges of mRNA delivery to specific cells in the lung tissues for treating a wide variety of diseases.
将系统性mRNA递送至特定细胞类型仍然是一项巨大挑战。我们在此报告了一类新型的冠状可生物降解可电离脂质(CBILs),通过利用金属配位化学实现可预测的肺选择性mRNA递送。每个CBIL都含有一个令人印象深刻的冠状氨基核心,它与锌等各种金属离子配位,并进一步调节脂质纳米颗粒(LNPs)在体内的器官靶向行为。代表性的由CBIL(Zn-9C-SCC-10)配制的LNPs在全身给药后可将mRNA特异性递送至肺部。值得注意的是,静脉注射0.2 mg/kg Cre mRNA后,Zn-9C-SCC-10 LNPs能够分别对高达43%和61%的所有肺上皮细胞和内皮细胞进行高效基因编辑,在肺上皮细胞递送方面优于当前最先进的LNPs。此外,与添加阳离子脂质(DOTAP)的DLin-MC3-DMA LNPs相比,我们的方法使肺部mRNA表达提高了44.6倍,并显著提高了体内生物安全性。利用顺磁性钆离子,Gd-12C-SCC-10 LNPs能够有效地将mRNA递送至癌细胞,并通过磁和生物发光双模态成像成功照亮肺部肿瘤,有助于肺癌的早期发现和诊断。这项工作将为合理设计可预测的LNPs开辟一条新途径,同时解决将mRNA递送至肺组织中特定细胞以治疗多种疾病的主要挑战。